Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.

× No keyword cloud information.

24 in total

1. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

Authors: G W Ashcroft; T B Crawford; D Eccleston; D F Sharman; E J MacDougall; J B Stanton; J K Binns
Journal: Lancet Date: 1966-11-12 Impact factor: 79.321

Review 2. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

Authors: A T Moir; G W Ashcroft; T B Crawford; D Eccleston; H C Guldberg
Journal: Brain Date: 1970 Impact factor: 13.501

3. Differential catechol-O-methyltransferase activity in unipolar and bipolar affective illness.

Authors: D L Dunner; C K Cohn; E S Gershon; F D Goodwin
Journal: Arch Gen Psychiatry Date: 1971-10

4. Clinical and pharmacological effects of monoamine precursors or haloperidol in chronic schizophrenia.

Authors: T Persson; B E Roos
Journal: Nature Date: 1968-03-02 Impact factor: 49.962

5. Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid.

Authors: M B Bowers
Journal: Brain Res Date: 1969-10 Impact factor: 3.252

6. Relationship of monoamine metabolites in human cerebrospinal fluid to age.

Authors: M B Bowers; F A Gerbode
Journal: Nature Date: 1968-09-21 Impact factor: 49.962

7. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.

Authors: H M van Praag; J Korf; J Puite
Journal: Nature Date: 1970-03-28 Impact factor: 49.962

8. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors: H C Guldberg; G W Ashcroft; T B Crawford
Journal: Life Sci Date: 1966-09 Impact factor: 5.037

9. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.

Authors: N H Neef; T N Tozer; B B Brodie
Journal: J Pharmacol Exp Ther Date: 1967-11 Impact factor: 4.030

10. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.

Authors: S J Dencker; U Malm; B E Roos; B Werdinius
Journal: J Neurochem Date: 1966-12 Impact factor: 5.372

19 in total

Review 1. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors: Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal: Neurosci Biobehav Rev Date: 2015-08-19 Impact factor: 8.989

2. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.

Authors: C M Banki
Journal: Eur J Clin Pharmacol Date: 1977-04-20 Impact factor: 2.953

3. Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma.

Authors: B M Emanuelsson; E Widerlöv; H Walléus; L K Paalzow
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

Review 4. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors: Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal: Eur J Pharmacol Date: 2014-08-05 Impact factor: 4.432

5. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.

Authors: L Bjerkenstedt; B Gullberg; C Härnryd; G Sedvall
Journal: Arch Psychiatr Nervenkr (1970) Date: 1977-10-11

6. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.

Authors: R Sjöström
Journal: Eur J Clin Pharmacol Date: 1973-08 Impact factor: 2.953

7. The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depression-syndrome.

Authors: P Riederer; W Birkmayer; E Neumayer; L Ambrozi; W Linauer
Journal: J Neural Transm Date: 1974 Impact factor: 3.575

8. A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation.

Authors: J F Deakin; I Pennell; A J Upadhyaya; R Lofthouse
Journal: Psychopharmacology (Berl) Date: 1990 Impact factor: 4.530

9. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation.

Authors: G Bucht; R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal: J Neural Transm Date: 1981 Impact factor: 3.575

Review 10. Dopamine and depression.

Authors: A S Brown; S Gershon
Journal: J Neural Transm Gen Sect Date: 1993